DYRK1B and ovarian carcinoma: The suppressive impact of DYRK1B on the cell cycle cannot only be observed in normal cells, but is also preserved in many cancer cell lines, such as those of ovarian cancer, non-small cell lung cancer, glioblastoma, and PDAC [65–70].